(0 items)
Small Medium Large | Print-Friendly Version of this Page  | Email this Page to a Friend
Skip Navigation Links
Page Layouts
Landing Page (wide)
Content Page (wide)
General Content
Annual Event
Lessons Learned from the Battlefield: Use of Whole Blood and Blood Components
News Release
2009 Award Page
Sample Newsletter
AABB > About AABB > Sample Layouts > Page Layouts > Lessons Learned from the Battlefield: Use of Whole Blood and Blood Components

Lessons Learned from the Battlefield: Use of Whole Blood and Blood Components 

10/7/2009   – 10/7/2009 
Audio Conference

Event Contact

Jerry Holmberg, PHD, MT(ASCP) SBB
Program # 094598  www.Google.com 

2:00 pm to 3:30 pm (ET) 6:00 pm to 7:30 pm (GMT)

Program # 094598


Director/Moderator: Jerry Holmberg, PhD, MT(ASCP)SBB, Senior Advisor for Blood Safety and Executive Secretary for the Advisory Committee on Blood Safety and Availability


Faculty: Commander Charles C.M. Lelkens, MD, Commanding Officer and Medical Director, Military Blood Bank, The Netherlands; Jeremy Perkins, MD, FACP, Chief, Hematology-Oncology Clinic, Walter Reed Army Medical Center


Intended Audience: Physicians, Scientists, Technologists, Nurses, Perfusionists



·          Describe various limitations and barriers in the battlefield that may be similar to everyday practice in any community.

·          Discuss massive transfusions in combat casualties including transfusion rates and mechanisms of injury.

·          Recall the various component therapies that are often used in massive battlefield trauma cases and how strategies change based on clinical condition as well as available component therapy.

·          Compare the indication, advantages, disadvantages and outcomes of various strategies to control bleeding and oxygen delivery in the battlefield trauma cases.

·          Discuss outcomes in massive transfusion relating various ratios of components given such as FFP:RBC ratios and platelet:RBC ratios.


Event Description: Throughout history, the experiences and challenges of treating the wounded on the battlefield have been a stimulus for advances in medicine. The field of transfusion medicine and component therapy has been the recipient of much experience, much based on necessity in the battlefield. Data driven indications for use of fresh whole blood (FWB) in trauma are unknown. Currently there are no randomized trials comparing whole blood to component therapy in the setting of trauma. FWB use is limited in the U.S., although the military routinely utilizes FWB in the setting of massive transfusion as both a source of platelets and other factors when large quantities of blood are required. Drawing from battlefield experience, the speakers of this audioconference will discuss challenges and strategies used in the battlefield. Discussion will include the use of component therapy, whole blood, and frozen blood in controlling hemostasis and maintaining oxygen delivery to the tissues in the wounded military and civilian patients.


Event Level: Intermediate to Advanced

Home  |  Site Map  | AABB © 2014. All rights reserved. |  Privacy Statement  |  Terms of Use